- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04226807
Impact of Earlier Postpartum Contact on Postpartum Visit Compliance and Maternal Wellbeing
November 3, 2022 updated by: Talitha Bruney, MD, Montefiore Medical Center
Re-imagining the Postpartum Process: The Impact of Earlier Postpartum Contact on Attendance at Postpartum Visits and Maternal Wellbeing
The American College of Obstetricians and Gynecologists has recommended a paradigm shift in how postpartum care is instituted.
They recommend that in addition to the normal 4-12 week postpartum visit, women receive contact with a provider within the first 3 weeks after giving birth.
This RCT will randomize patients to routine care- 6-12 week postpartum visit alone- or enhanced care- routine care plus a phone call within the first 3 weeks postpartum.
The patients will then be asked to complete a follow up survey at 6 months postpartum.
The primary outcome measure would be rates of compliance with the 6-12 week postpartum visit.
Secondary outcome measures will include breastfeeding rates, rates of postpartum depression, hospital readmission rates and met desire for contraception.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Bronx, New York, United States, 10461
- Montefiore Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Had a vaginal or cesarean delivery at the Jack D. Weiler Hospital
- Gestational age greater than or equal to 36 weeks
- Received prenatal care at the Comprehensive Family Care Center (CFCC) clinic
Exclusion Criteria:
- Fetal or neonatal death or demise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Early Postpartum Contact
Patient receive a phone call from research staff 2-3 weeks after giving birth in addition to routine postpartum visit
|
Participants receive a phone call 2-3 weeks after birth asking about overall wellbeing, screening for complications and postpartum depression and referring to lactation or WIC as needed.
|
No Intervention: Routine Postpartum Care
Patient receives routine postpartum visit only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Attendance at comprehensive postpartum care visit
Time Frame: 12 weeks postpartum
|
Percentage of women attending comprehensive postpartum visit
|
12 weeks postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Breastfeeding rates at 6 months
Time Frame: 6 months postpartum
|
Percentage of women exclusively breastfeeding, using combined breastfeeding and formula feeding or exclusively using formula.
|
6 months postpartum
|
Need for family planning met
Time Frame: 6 months postpartum
|
Percentage of women who want to be using a birth control method who are using one
|
6 months postpartum
|
Social work referral
Time Frame: 6 months postpartum
|
Percentage of women who attend a social work appointment
|
6 months postpartum
|
Repeat pregnancy within 6 months of delivery
Time Frame: 6 months postpartum
|
Percentage of women with a positive pregnancy test since delivery
|
6 months postpartum
|
Readmission to the hospital
Time Frame: 6 months postpartum
|
Percentage of women admitted to any Montefiore hospital
|
6 months postpartum
|
Acceptability of early visit
Time Frame: 6 months postpartum
|
Percentage of women who were "Very Satisfied" or "Satisfied" with the early phone call
|
6 months postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Talitha Bruney, MD, Montefiore Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, Gonzalez-Medina D, Barber R, Huynh C, Dicker D, Templin T, Wolock TM, Ozgoren AA, Abd-Allah F, Abera SF, Abubakar I, Achoki T, Adelekan A, Ademi Z, Adou AK, Adsuar JC, Agardh EE, Akena D, Alasfoor D, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Al Kahbouri MJ, Alla F, Allen PJ, AlMazroa MA, Alsharif U, Alvarez E, Alvis-Guzman N, Amankwaa AA, Amare AT, Amini H, Ammar W, Antonio CA, Anwari P, Arnlov J, Arsenijevic VS, Artaman A, Asad MM, Asghar RJ, Assadi R, Atkins LS, Badawi A, Balakrishnan K, Basu A, Basu S, Beardsley J, Bedi N, Bekele T, Bell ML, Bernabe E, Beyene TJ, Bhutta Z, Bin Abdulhak A, Blore JD, Basara BB, Bose D, Breitborde N, Cardenas R, Castaneda-Orjuela CA, Castro RE, Catala-Lopez F, Cavlin A, Chang JC, Che X, Christophi CA, Chugh SS, Cirillo M, Colquhoun SM, Cooper LT, Cooper C, da Costa Leite I, Dandona L, Dandona R, Davis A, Dayama A, Degenhardt L, De Leo D, del Pozo-Cruz B, Deribe K, Dessalegn M, deVeber GA, Dharmaratne SD, Dilmen U, Ding EL, Dorrington RE, Driscoll TR, Ermakov SP, Esteghamati A, Faraon EJ, Farzadfar F, Felicio MM, Fereshtehnejad SM, de Lima GM, Forouzanfar MH, Franca EB, Gaffikin L, Gambashidze K, Gankpe FG, Garcia AC, Geleijnse JM, Gibney KB, Giroud M, Glaser EL, Goginashvili K, Gona P, Gonzalez-Castell D, Goto A, Gouda HN, Gugnani HC, Gupta R, Gupta R, Hafezi-Nejad N, Hamadeh RR, Hammami M, Hankey GJ, Harb HL, Havmoeller R, Hay SI, Pi IB, Hoek HW, Hosgood HD, Hoy DG, Husseini A, Idrisov BT, Innos K, Inoue M, Jacobsen KH, Jahangir E, Jee SH, Jensen PN, Jha V, Jiang G, Jonas JB, Juel K, Kabagambe EK, Kan H, Karam NE, Karch A, Karema CK, Kaul A, Kawakami N, Kazanjan K, Kazi DS, Kemp AH, Kengne AP, Kereselidze M, Khader YS, Khalifa SE, Khan EA, Khang YH, Knibbs L, Kokubo Y, Kosen S, Defo BK, Kulkarni C, Kulkarni VS, Kumar GA, Kumar K, Kumar RB, Kwan G, Lai T, Lalloo R, Lam H, Lansingh VC, Larsson A, Lee JT, Leigh J, Leinsalu M, Leung R, Li X, Li Y, Li Y, Liang J, Liang X, Lim SS, Lin HH, Lipshultz SE, Liu S, Liu Y, Lloyd BK, London SJ, Lotufo PA, Ma J, Ma S, Machado VM, Mainoo NK, Majdan M, Mapoma CC, Marcenes W, Marzan MB, Mason-Jones AJ, Mehndiratta MM, Mejia-Rodriguez F, Memish ZA, Mendoza W, Miller TR, Mills EJ, Mokdad AH, Mola GL, Monasta L, de la Cruz Monis J, Hernandez JC, Moore AR, Moradi-Lakeh M, Mori R, Mueller UO, Mukaigawara M, Naheed A, Naidoo KS, Nand D, Nangia V, Nash D, Nejjari C, Nelson RG, Neupane SP, Newton CR, Ng M, Nieuwenhuijsen MJ, Nisar MI, Nolte S, Norheim OF, Nyakarahuka L, Oh IH, Ohkubo T, Olusanya BO, Omer SB, Opio JN, Orisakwe OE, Pandian JD, Papachristou C, Park JH, Caicedo AJ, Patten SB, Paul VK, Pavlin BI, Pearce N, Pereira DM, Pesudovs K, Petzold M, Poenaru D, Polanczyk GV, Polinder S, Pope D, Pourmalek F, Qato D, Quistberg DA, Rafay A, Rahimi K, Rahimi-Movaghar V, ur Rahman S, Raju M, Rana SM, Refaat A, Ronfani L, Roy N, Pimienta TG, Sahraian MA, Salomon JA, Sampson U, Santos IS, Sawhney M, Sayinzoga F, Schneider IJ, Schumacher A, Schwebel DC, Seedat S, Sepanlou SG, Servan-Mori EE, Shakh-Nazarova M, Sheikhbahaei S, Shibuya K, Shin HH, Shiue I, Sigfusdottir ID, Silberberg DH, Silva AP, Singh JA, Skirbekk V, Sliwa K, Soshnikov SS, Sposato LA, Sreeramareddy CT, Stroumpoulis K, Sturua L, Sykes BL, Tabb KM, Talongwa RT, Tan F, Teixeira CM, Tenkorang EY, Terkawi AS, Thorne-Lyman AL, Tirschwell DL, Towbin JA, Tran BX, Tsilimbaris M, Uchendu US, Ukwaja KN, Undurraga EA, Uzun SB, Vallely AJ, van Gool CH, Vasankari TJ, Vavilala MS, Venketasubramanian N, Villalpando S, Violante FS, Vlassov VV, Vos T, Waller S, Wang H, Wang L, Wang X, Wang Y, Weichenthal S, Weiderpass E, Weintraub RG, Westerman R, Wilkinson JD, Woldeyohannes SM, Wong JQ, Wordofa MA, Xu G, Yang YC, Yano Y, Yentur GK, Yip P, Yonemoto N, Yoon SJ, Younis MZ, Yu C, Jin KY, El Sayed Zaki M, Zhao Y, Zheng Y, Zhou M, Zhu J, Zou XN, Lopez AD, Naghavi M, Murray CJ, Lozano R. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Sep 13;384(9947):980-1004. doi: 10.1016/S0140-6736(14)60696-6. Epub 2014 May 2. Erratum In: Lancet. 2014 Sep 13;384(9947):956.
- ACOG Committee Opinion No. 736: Optimizing Postpartum Care. Obstet Gynecol. 2018 May;131(5):e140-e150. doi: 10.1097/AOG.0000000000002633.
- Wilcox A, Levi EE, Garrett JM. Predictors of Non-Attendance to the Postpartum Follow-up Visit. Matern Child Health J. 2016 Nov;20(Suppl 1):22-27. doi: 10.1007/s10995-016-2184-9.
- Baldwin MK, Hart KD, Rodriguez MI. Predictors for follow-up among postpartum patients enrolled in a clinical trial. Contraception. 2018 Sep;98(3):228-231. doi: 10.1016/j.contraception.2018.04.016. Epub 2018 May 8.
- Tsai PJ, Nakashima L, Yamamoto J, Ngo L, Kaneshiro B. Postpartum follow-up rates before and after the postpartum follow-up initiative at Queen Emma Clinic. Hawaii Med J. 2011 Mar;70(3):56-9.
- Chen MJ, Hsia JK, Hou MY, Wilson MD, Creinin MD. Comparing Postpartum Visit Attendance with a Scheduled 2- to 3-Week or 6-Week Visit after Delivery. Am J Perinatol. 2019 Jul;36(9):936-942. doi: 10.1055/s-0038-1675623. Epub 2018 Nov 10.
- Goulet L, D'Amour D, Pineault R. Type and timing of services following postnatal discharge: do they make a difference? Women Health. 2007;45(4):19-39. doi: 10.1300/J013v45n04_02.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 31, 2021
Primary Completion (Actual)
January 31, 2022
Study Completion (Actual)
January 31, 2022
Study Registration Dates
First Submitted
January 9, 2020
First Submitted That Met QC Criteria
January 9, 2020
First Posted (Actual)
January 13, 2020
Study Record Updates
Last Update Posted (Actual)
November 8, 2022
Last Update Submitted That Met QC Criteria
November 3, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2019-10372
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postpartum Care
-
University of PittsburghCompletedPostpartum Care
-
University of PittsburghNational Institute of Nursing Research (NINR)CompletedPostpartum CareUnited States
-
MDRCJohns Hopkins University; Centers for Medicare and Medicaid Services; Mathematica... and other collaboratorsCompletedPregnancy | Infant Development | Postpartum CareUnited States
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingContraception | Breastfeeding | Preventive Care / Anticipatory Guidance | Retention in Care | Postpartum HealthUnited States
-
University of MichiganFood and Drug Administration (FDA)Active, not recruitingPostpartum Pain | Opioid Stewardship | Maternity Care | Obstetric CareUnited States
-
Saglik Bilimleri UniversitesiCompleted
-
JhpiegoUnited States Agency for International Development (USAID); Bill and Melinda...CompletedPregnancy | Contraception | Contraceptive Usage | Prenatal Care | Postpartum Family PlanningEthiopia
-
University of Illinois at ChicagoAgency for Healthcare Research and Quality (AHRQ)CompletedContraception Behavior | Women's Health | Primary Health Care | Postpartum PeriodUnited States
-
Nigde Omer Halisdemir UniversityTC Erciyes UniversityCompletedFatigue | Mood | Comfort | Postpartum CareTurkey
-
University of Notre DameIndiana University School of Medicine; Savana SignaturesRecruiting
Clinical Trials on Early Postpartum Phone Call
-
Baoshan Prefecture Center for Disease Control and...Prince of Songkla UniversityUnknownMedication AdherenceChina
-
Women and Infants Hospital of Rhode IslandCompletedPostpartum Depression | Satisfaction, Patient | Breastfeeding | Postpartum Disorder | Postpartum Weight Retention | TrustUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMild Traumatic Brain InjuryFrance
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Hospices Civils de LyonRecruitingPancreatic Cancer | Surgery | ElderlyFrance
-
Groupe Hospitalier de Bretagne SudRecruitingProstate Cancer | RadiotherapyFrance
-
University Hospital, ToulouseCompletedPost Traumatic Stress DisorderFrance
-
University of Texas at AustinMeals on Wheels Central TexasCompletedDepression | Loneliness | Social IsolationUnited States
-
Laboratoires InnotheraFloralisRecruitingPost Thrombotic SyndromeFrance
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital; BJC Innovative LabTerminatedAbdominal SurgeryUnited States